Astria Therapeutics Inc. (ATXS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Astria Therapeutics Inc.

    NASDAQ: ATXS · Real-Time Price · USD
    7.52
    -0.17 (-2.21%)
    At close: Oct 03, 2025, 3:59 PM
    7.80
    3.72%
    After-hours: Oct 03, 2025, 06:33 PM EDT

    Astria Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.33 -3.17 -4.2 -0.25
    PEG Ratio
    		 0.17 0.10 0.05 -0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.57 0.95 0.98 0.39
    P/FCF Ratio
    		 -6.16 -3.38 -4.99 -1.59
    P/OCF Ratio
    		 -6.18 -3.38 -5 -1.6
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.00 0.00 0.00
    Quick Ratio
    		 17.49 21.73 25.13 24.42
    Current Ratio
    		 17.49 21.73 25.13 24.42
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.3 -0.3 -0.23 -1.59
    Return on Assets
    		 -0.28 -0.29 -0.22 -1.53
    Return on Invested Capital
    		 -0.34 -0.34 -0.24 -0.25
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist